Brooks Gabriel
Chief Medical Officer
Brooks Gabriel has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company, with disclosures dating back to 2025. 4 of those filings fall inside the rolling window. Most recent filing: Feb 18, 2026.
On the most recent filing, Brooks Gabriel is listed as Chief Medical Officer at Solid Biosciences Inc. Inside the rolling window, Brooks Gabriel reported no open-market purchases and 3 open-market sales totaling $281K in SLDB. The largest disclosed transaction in the window is a sale of 28,335 SLDB shares on Feb 2, 2026, worth $182K.
Companies traded
Other insiders at SLDB
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$281K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Brooks Gabriel made?
Brooks Gabriel has filed 4 SEC Form 4 filings (7 transaction rows) across 1 company since 2025.
Which companies does Brooks Gabriel trade?
Brooks Gabriel has filed SEC Form 4 disclosures for 1 company, including SLDB.
When was Brooks Gabriel's most recent SEC Form 4 filing?
Brooks Gabriel's most recent SEC Form 4 filing on Tracefour is dated Feb 18, 2026.
What is Brooks Gabriel's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Brooks Gabriel is listed as Chief Medical Officer.
What is Brooks Gabriel's total buy and sell value in the current window?
Inside the rolling retention window, Brooks Gabriel bought $0 and sold $281K based on SEC Form 4 filings.
What was Brooks Gabriel's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 28,335 SLDB shares on 2026-02-02, worth $182K, per SEC Form 4 filings.